Abstracts

Association of Gag-Specific CD28+CD95+ CD8+ T-Cell Responses in Lymph Nodes With Lower Viral Loads

Background: Cumulative studies have suggested that HIV replication can be controlled by potent CD8+ T-cell responses. Individual viral proteins show different kinetics of expression and degradation, which affect efficacy of protein-derived epitope presentation to CD8+ T cells. Thus, some viral proteins can be the targets for effective CD8+ T cells more frequently. CD8+ T-cell responses…

CD8+ T Cells From HLA-B*57 Elite Suppressors Inhibit Replication of HIV-1 Escape Mutants

Background: Elite Controllers or Suppressors (ES) are individuals who maintain undetectable plasma viral loads by standard clinical assays in the absence of antiretroviral therapy. Multiple lines of evidence suggest that the control of viral replication in these patients is due to a strong and specific cytotoxic T lymphocyte (CTL) response. Escape mutations are believed to…

Linkage Between Disease Status and a Naturally Arising Mutation in Functional Region of HIV-1 Nef

Background: HLA class-I(HLA-I) downregulation by HIV-1 Nef has been shown to protect infected cells from CTL killing, thereby contributing to viral persistence in vivo. It achieves this through a number of highly conserved sequence (functional) domains. However, the in vivo implication(s) of naturally arising polymorphism(s) in HIV-1 Nef’s published functional domains associated with HLA-I down-regulation,…

Complex Impact of Reversion Mutations and CD8+ T Cell Escape Mutations on HIV-1 Fitness

Background: Mutations that revert back to the ancestral state frequently occur in the HIV-1 genome during infection and have been considered to render the viruses more fit. However, their impact on viral fitness and interactions with the immune escape mutations have not been evaluated in their cognate transmitted/founder (T/F) viral genomes. Methodology: Our previous study…

HIV Cell Tropism Dependent Impact of CTL Escape Mutations in Gag on Viral Replicative Capacity

Background: KK10 (K263-K272) within the N-terminus of HIV p24/Gag represents the immunodominantly targeted CTL epitope in HLA-B27+ HIVinfected individuals. Due to its association with delayed disease progression B27 is considered to be protective during HIV infection. The stereotypical escape mutation R264K alters the KK10 epitope in a way that it is no longer presented by…

HIV-1 gp120-specific Antibody Dependent Cell-mediated Cytotoxicity in HIV-1 Elite Controllers

Background: In the Thai RV144 HIV vaccine trial, antibody dependent cell-mediated cytotoxicity (ADCC) is the only vaccine induced immunological parameter that correlates inversely with infection. This suggests that protective HIV specific ADCC can be stimulated by vaccination. We hypothesized that natural production of HIV-specific ADCC antibodies may also be protective and that these antibodies may…

Transient Compartmentalization of SIV Variants in the Breast Milk of African Green Monkeys

Background: In contrast to HIV-infected humans and SIV-infected rhesus monkeys, natural hosts of SIV, African green monkeys (AGMs), rarely transmit the virus postnatally. Previous studies in humans and rhesus monkeys revealed that breast milk populations of humans and rhesus monkeys are not genetically distinct from those in plasma. As the breast milk virus population of…

Antiretroviral Switch Strategies for Lowering Costs of Therapy: 48-Week Cost-efficacy Analysis

Background: The economic recession has led to a generalized shortage of investment in public health and the antiretroviral treatment (ART) budget in some European countries. Some ART were proactively switched in selected individuals to generate cost savings. We undertook a complete 48 week costefficacy analysis to evaluate this strategy. Methodology: We defined cost-reduction measures (CRM)…